Signaling triggered by polypeptide growth factors leads to the activation of their target genes. Several homeobox genes are known to be induced in response to polypeptide growth factors in early Xenopus development. In particular, Xmsx-1, an amphibian homologue of vertebrate Msx-1, is well characterized as a target gene of bone morphogenetic protein (BMP). Here, using a dominant-negative form of Xmsx-1 (VP-Xmsx-1), which is a fusion protein made with the virus-derived VP16 activation domain, we have examined whether Xmsx-1 activity is required in the endogenous ventralizing pathway. VP-Xmsx-1 induced a secondary body axis, complete with muscle and neural tissues, when overexpressed in ventral blastomeres, suggesting that Xmsx-1 activity is necessary for both mesoderm and ectoderm to be ventralized. We have also examined the epistatic relationship between Xmsx-1 and another ventralizing homeobox protein, Xvent-1, and show that Xmsx-1 is likely to be acting upstream of Xvent-1. We propose that Xmsx-1 is required in the BMP-stimulated ventralization pathway that involves the downstream activation of Xvent-1. q
Introduction
Cell-to-cell interactions during development are regulated by a number of polypeptide growth factors which are secreted from one type of cell and act on other types of target cells to determine their fate (Nusse and Varmus, 1992; Sive, 1993; Boonstra et al., 1995; Hogan, 1996; Szebenyi and Fallon, 1999) . The activities of these factors are known to be mediated through membrane receptors, intracellular signaling factors, and nuclear transcriptional factors and their coactivators in the target cells (Gotoh and Nishida, 1995; Miller and Moon, 1996; Derynck et al., 1998; Jans and Hassan, 1998) . As a result of signal activation, information from individual growth factors leads to the induction of their target genes, including homeobox transcription factors (Botas, 1993) , which in turn direct secondary gene activation or repression. Recent studies have revealed that some of these transcriptional regulators are immediate early genes responding to polypeptide growth factors' stimuli and have critical roles in cell differentiation during early development (Ladher et al., 1996; Suzuki et al., 1997b) .
In Xenopus, dorsal mesoderm-inducing signals represented by activin, Vg1, and nodal (Smith et al., 1990; Thomsen et al., 1990; Jones et al., 1995; Kessler and Melton, 1995) have been shown to induce a number of transcriptional factors including a homeobox protein called goosecoid (Cho et al., 1991) and the LIM-homeo domain protein Xlim-1 (Taira et al., 1992) , both of whose expression is restricted to the organizer region. Thus, these genes are called`organizer-speci®c' genes. Similarly, ventral inducers of BMP have been shown to activate the transcription of several homeobox genes; Xvent-1/PV.1 (Gawantka et al., 1995; Ault et al., 1996) , Xvent-2/Xom/Vox/Xbr-1 (Ladher et al., 1996; Onichtchouk et al., 1996; Papalopulu and Kintner, 1996; Schmidt et al., 1996) , Xmsx-1 Suzuki et al., 1997b) , and mouse Dlx5 (Miyama et al., 1999) . It is interesting to note that all these genes are not only induced by BMP-4 but also have the capacity to ventralize embryos when ectopically expressed in the dorsal blastomeres, mimicking the effect of BMP-4 (Gawantka et al., 1995; Ault et al., 1996; Ladher et al., 1996; Onichtchouk et al., 1996; Schmidt et al., 1996; Maeda et al., 1997; Suzuki et al., 1997b; Miyama et al., 1999) . Among these, Msx-1 (Davidson, 1995; Boncinelli, 1997) , the mouse counterpart of Xmsx-1, has a well characterized role in organogenesis. In the mouse, Msx-1 and Msx-2 mediate epithelial± mesenchymal interactions in tooth induction; Msx-1 is induced in dental mesenchyme by epithelially expressed BMP-4 (Vainio et al., 1993) . BMP-4 also requires Msx-1 to induce its own expression in mesenchyme, suggesting a genetic cascade in tooth development: BMP-4 (epithelium)± Msx-1 (mesenchyme)±BMP-4 (mesenchyme) (Chen et al., 1996) . In addition, Msx-1 is induced by BMP-2 in the neural crest in rhombomeres 3 and 5 (Graham et al., 1994) . The expression of BMP-2 in the hindbrain is implicated in the induction of apoptosis through the activity of Msx-1, which eliminates neural crest cells from the rhombomeres (Graham et al., 1994) . In addition to tooth development and the establishment of rhombomere identity, the cascade also seems to be present in limb formation (Vogel et al., 1995) and craniofacial development (Foerst-Potts and Sadler, 1997) .
Thus, a growing body of experimental evidence suggests that Msx genes are both targets and essential mediators of BMP signaling. In Xenopus embryogenesis, Xmsx-1 is expressed in both ventral mesoderm and ectoderm, and its expression overlaps with that of BMP-4 Suzuki et al., 1997b) . In fact, Xmsx-1 is induced in animal cap cells as an immediate early gene, in response to BMP receptor activation (Suzuki et al., 1997b) . In experiments where a dominant-negative BMP receptor was used to block the BMP signal, ectopically expressed Xmsx-1 acted downstream of the BMP receptors to restore the BMP signal (Suzuki et al., 1997b) , suggesting that Xmsx-1 has a major role in BMP signaling.
In this study, we generated functional derivatives of Xmsx-1 by constructing a cDNA that encodes an Xmsx-1 protein fused with the transactivation domain of virusderived VP16 (Friedman et al., 1988) or with the repressor domain of the Drosophila even-skipped protein (Han and Manley, 1993) . Our functional analysis using early Xenopus embryos showed that VP-Xmsx-1 but not eve-Xmsx-1 inhibits the effect of overexpressed Xmsx-1, suggesting that Xmsx-1 is likely to be a transcriptional suppressor. Using the dominant-negative Xmsx-1, we also found that Xmsx-1 is required for the ventralization triggered by BMP. Furthermore, we demonstrated that Xmsx-1 acts upstream of another ventralizing homeobox gene, Xvent-1. Finally, we propose that there is a hierarchy of homeobox genes in the ventralizing pathway responding to BMP.
Results

VP-Xmsx-1 inhibits Xmsx-1 activity
Although it was previously reported that Xmsx-1 is suf®-cient to exert a BMP-like activity, namely the ventralization of embryos, when dorsally overexpressed Suzuki et al., 1997b) , the requirement for Xmsx-1 in the ventralization pathway triggered by BMP was not clear. We, therefore, attempted to inhibit the function of endogenous Xmsx-1 by using functional variants of Xmsx-1. We generated three cDNAs that encode (a) the N-terminally deleted form of Xmsx-1, (b) a fusion protein of Xmsx-1 with the transactivation domain derived from VP16 (Friedman et al., 1988) , and (c) the repressor domain of the even-skipped (eve) gene product (Han and Manley, 1993) (Fig. 1) . We expected to give useful information about the endogenous role of Xmsx-1 as a transcriptional activator or repressor by using our constructs to force the activation or inactivation of Xmsx-1 target genes, a strategy that has been productive in other instances (Conlon et al., 1996; Ferreiro et al., 1998; Onichtchouk et al., 1998) . Therefore, mRNAs were synthesized from these cDNAs and injected into early Xenopus embryos to ascertain their functions in terms of ventralizing activity. As reported previously, Xmsx-1 mRNA alone induced a ventralized phenotype, with an average dorsoanterior index (Av.DAI) of 3.2 (n 27) (Kao and Elinson, 1988) , when overexpressed in dorsal blastomeres, which resembles the phenotype induced by BMP overexpression ( Fig. 2A) Suzuki et al., 1997b) . First, we examined whether any of our arti®cial variants of Xmsx-1 could suppress the ventralized phenotype caused by the overexpression of wild-type Xmsx-1. The ventralizing effect of wild-type Xmsx-1 was almost completely inhibited by the coexpression of VP-Xmsx-1 (Av.DAI 4.7, n 29) (Fig. 2B) , while no or slightly enhanced ventralization was observed by coexpression of eve-Xmsx-1 (data not shown). To evaluate the speci®city of VP-Xmsx-1, we used two other homeobox genes, Msx-2 and Xdll-3, whose primary structures are similar to Xmsx-1 (amino acid sequence identity in homeodomain and overall structure: Msx-2, 100 and 54.9%; Xdll-3, 56.7 and 25.8%, respectively). Each mRNA was coinjected with VP-Xmsx-1 mRNA. Msx-2 is the most homologous to Msx-1 of all known gene products, and both amino acid sequences are completely identical in their homeodomains. Xdll-3 (Papalopulu and Kintner, 1993 ) is a Xenopus homeobox protein most similar to Dlx-5 in other vertebrates, which has recently been identi®ed as a target gene of BMP-2/4 (Miyama et al., 1999) . We also showed that overexpression of Xdll-3 (Fig. 2C ) or mouse Msx-2 (mMsx-2, data not shown) in dorsal blastomeres resulted in the ventralization of the embryo, mimicking the effect of BMP and Xmsx-1, and demonstrating that they are also ventralizing homeobox proteins. VP-Xmsx-1 did not rescue the Xdll-3-induced ventralized embryo to any extent (Fig. 2D) , although it did show a weak rescuing ability for the mMsx-2-induced ventralization (data not shown), indicating that VP-Xmsx-1 is a speci®c inhibitor of Xmsx-1, but leaving the possibility of weak cross-reaction with Msx-2 target sequences open. We also found that VP-Xmsx-1 does not rescue the ventralized phenotype caused by Xvent-1 or -2 (Gawantka et al., 1995; Onichtchouk et al., 1996) (see discussion on the epistatic relationship between Xmsx-1 and Xvents below). Neither the VP16 activation domain nor the Nterminally deleted form of Xmsx-1, when expressed alone, had much effect on the ventralization induced by Xmsx-1 (data not shown). Thus, the inhibitory activity of VP-Xmsx-1 against wild-type Xmsx-1 is speci®c to the fusion construct, indicating that the target genes recognized by the C-terminal region of Xmsx-1, including the homeobox, were subjected to forced activation. These data suggest that the VP-Xmsx-1 acts in a dominant-negative manner to inhibit native Xmsx-1.
Xmsx-1 is a transcriptional repressor
We next used VP-Xmsx-1 mRNA to inhibit the endogenous Xmsx-1 activity. Xmsx-1 is expressed in the ventral half of embryos at the early gastrula stage Suzuki et al., 1997b) . Thus, it is believed to be a downstream mediator of BMP-4, which is also expressed in ventral mesoderm and ectoderm (Hemmati-Brivanlou and Thomsen, 1995) . Overexpression of VP-Xmsx-1 in the ventral blastomeres caused the development of a partial secondary body axis (85.7%, n 28) (Fig. 3Ab) . Hematoxylin and eosin staining showed that the secondary body axis contained muscle and neural tissues but no recognizable notochord (Fig. 3C ). This secondary body axis is similar to that induced by ventral overexpression of a dominantnegative BMP type I receptor (dnBMPR-IA) (Maeno et al., 1994; Suzuki et al., 1994) . Thus, it appeared that as a consequence of the inhibition of endogenous Xmsx-1 by VP-Xmsx-1, the ventral mesoderm and ectoderm were respeci®ed to become the respective dorsal tissues. To con®rm this possibility, we coinjected wild-type Xmsx-1 mRNA with VP-Xmsx-1 mRNA into the ventral blastomeres to see whether the native Xmsx-1 could cancel the dorsalizing effect of VP-Xmsx-1. As shown in Fig. 3Ac , the dorsalized phenotype was almost completely rescued (0%, n 33). In contrast, ventral overexpression of eve-Xmsx-1 did not induce a secondary body axis ( Fig. 3Ae ) and overexpression of eve-Xmsx-1 in dorsal blastomeres ventralized the embryo (Av.DAI 2.2, n 25) (Fig. 3Ad) , similar to the result with wild-type Xmsx-1 overexpression, showing that fusion of Xmsx-1 to the eve repressor domain retained the original activity of Xmsx-1. Taken together, these results
show that forced transactivation of Xmsx target genes via the VP16 domain disrupted the normal function of endogenous Xmsx-1, and that Xmsx-1 may act as a transcriptional repressor in vivo.
To con®rm the dorsalizing effect of VP-Xmsx-1 at the molecular level, particularly in mesoderm, we examined the expression level of mesodermal and other marker genes by RT-PCR (Fig. 3B) . Ventral mesoderm was excised from embryos ventrally overexpressing VP-Xmsx-1. Dorsal markers, goosecoid, chordin (Fig. 3B ) and noggin (data not shown), all of which mark Spemann's organizer (Cho et al., 1991; Sasai et al., 1994) , were upregulated in the ventral marginal zone (VMZ). Xmyf-5, which marks dorsolateral mesoderm (Hopwood et al., 1991) was also upregulated. On the other hand, the expression of the ventrolateral marker Xwnt-8 (Christian and Moon, 1993 ) was attenuated to some extent, and the ventral marker Xvent-1 was ef®-ciently suppressed. Interestingly, all of the genes that were upregulated by VP-Xmsx-1 overexpression are normally suppressed in the dorsal marginal zone (DMZ) by Xmsx-1 or BMP overexpression, as shown in Fig. 4 . This result further supports the idea that Xmsx-1 is a transcriptional repressor and its target genes include organizer-speci®c genes such as goosecoid and chordin. Conversely, expression of Xwnt-8 and Xvent-1 appears to be increased by Xmsx-1 activity, because they are downregulated by overexpression of VP-Xmsx-1 and upregulated by wild-type Xmsx-1. Given the nature of Xmsx-1 as a transcriptional repressor, Xmsx-1 may be repressing another repressor(s) acting on the upstream sequences of these genes.
VP-Xmsx-1 induces neural fate in ectoderm
Expression of Xmsx-1 mRNA is detected by RT-PCR in early embryonic development, starting at stage 4. Xmsx-1 is highly expressed in the ectoderm (animal cap) of stage 8 1/2 embryos, as is BMP-4 (Suzuki et al., 1997b ). The endogenous level of BMP-4 is thought to be necessary and suf®cient to direct the ectoderm to differentiate into epidermis. Therefore, the dispersion of animal cap cells to remove the BMP-4 ligand, or the inhibition of BMP signal in animal cap cells by a dominant-negative BMP receptor leads to a loss of Xmsx-1 expression (Suzuki et al., 1997b) as well as to the autonomous differentiation of the cells into neural tissues, as assessed by the expression of neural markers such as Zic-3 and NCAM (Fig. 5, lane 3) . Based on this knowledge, we examined whether the loss of Xmsx-1 function in the animal cap would cause neural induction. VP-Xmsx-1 mRNA (250 pg) microinjected into the animal poles of two-cell embryos induced NCAM and Zic-3 expression (Fig. 5, lane 2) . The effect was similar to that caused by a dominant-negative BMP receptor (dnBMPR-IA), suggesting that VP-Xmsx-1 inhibited the signaling of BMP by blocking the function of Xmsx-1. This prediction was con®rmed by the observation that coexpression of Xmsx-1 with dnBMPR-IA canceled the neural marker expression (Fig. 5, lanes 3 and 4) , consistent with a previous observation (Suzuki et al., 1997b) . Taken together, these ®ndings indicate that Xmsx-1 is an essential mediator of BMP activity, and inhibition of Xmsx-1 activity is suf®cient to induce neural fate in the ectoderm.
Xvent-1 acts downstream of Xmsx-1
It was previously reported that homeobox genes Xvent-1 (Gawantka et al., 1995) and Xvent-2 (Onichtchouk et al., 1996) are BMP-2/BMP-4-responsive genes. These genes are also expressed ventrolaterally and not in the dorsalmost region of early embryos, although the intensity of wholemount in situ hybridization staining for these transcripts is relatively weak in ectoderm, compared with that for Xmsx-1. Xvent-1 and Xvent-2 were shown to mediate BMP activities, particularly in the ventralization of embryos in a manner reminiscent of Xmsx-1 gene. Our results (Figs. 3B and 4) suggest that Xvent-1 but not Xvent-2 expression is dependent on the activity of Xmsx-1 because loss-of-function and gain-of-function manipulations of Xmsx-1 led to downregulation and upregulation of Xvent-1 expression, respectively, despite the lack of effect on Xvent-2 expression. To examine whether Xmsx-1 and Xvent-1 act in the same pathway, we analyzed the epistatic relationship between Xmsx-1 and Xvent-1. First, we tested whether dorsalization by ventral expression of VP-Xmsx-1 could be rescued by coexpression of wild-type Xvent-1 or Xvent-2. As shown in Fig. Fig. 4 . Reciprocal effect of wild-type Xmsx-1 and VP-Xmsx-1 on marker gene expression. Embryos were either uninjected (lanes 1, 4 and 5) or injected with 400 pg of Xmsx-1 (lane 2) or 200 pg of BMP-4 (lane 3) mRNA into the equatorial region of the two dorsal blastomeres at the four-cell stage. Dorsal marginal zone explants (DMZ; lanes 1±3) were cultured until sibling embryos reached stage 11. Wild-type Xmsx-1 repressed and activated the expression of the genes activated and repressed by VP-Xmsx-1 (Fig. 3B) , respectively. 6A, VP-Xmsx-1-induced dorsalized phenotypes (81% secondary axis, n 32) (Fig. 6Aa) were successfully rescued by coexpression of Xvent-1 (84% normal, n 28) (Fig. 6Ab) , while the rescuing ability of Xvent-2 seemed to be lower than Xvent 1 (no secondary axis but Av.DAI 6.0, n 35). Marker gene expression also supported the idea that dorsalization by VP-Xmsx-1 was suppressed by Xvent-1 (data not shown). Moreover, overexpression of Xvent-1 in the dorsal marginal zone failed to induce Xmsx-1, while the ventrolateral marker Xwnt-8 was induced and the dorsal markers chordin and goosecoid were completely suppressed (Fig. 6B) , con®rming Xvent-1's ventralizing ability. To eliminate the possibility that the induction of Xvent-1 by Xmsx-1 was caused by an increased level of BMP ligand, we examined the expression level of BMP in the DMZ of Xmsx-1-expressing embryos. There was no increase in BMP-2 or BMP-4 expression (data not shown). Taken together, these data suggest that Xvent-1 acts downstream but not upstream of Xmsx-1. To further con®rm this sequence of events, we tested whether ventralization by Xvent-1 could be rescued by VP-Xmsx-1. If Xvent-1 acts downstream of Xmsx-1, the ventralized phenotype caused by increased levels of Xvent-1 activity should not be rescued by a dominant-negative mutant of the upstream gene Xmsx-1. As expected, the ventralized Xvent-1 phenotype (Av.DAI 2.0, n 29) (Fig. 6Ac) was not rescued by VP-Xmsx-1 (Av.DAI 2.1, n 31) (Fig. 6Ad) . Conversely, ventralization by wild-type Xmsx-1 (Av.DAI 2.3, n 29) (Fig. 6Ae) was partially rescued by VP-Xvent-1 (Av.DAI 4.0, n 31) (Fig. 6Af) , which was previously shown to interfere with Xvent-1 function and consequently to cause dorsalization of mesoderm and neural induction (Onichtchouk et al., 1998) . Taken together, and given that Xmsx-1 is an immediate early BMP-responsive gene, these results suggest that Xmsx-1 functions upstream of Xvent-1.
Xmsx-1 is required for early responses to ventralization by BMP
It is well established that BMP-4 is essential for the speci®cation of both ventral mesoderm and ectoderm, and thus it seems likely that Xmsx-1 mediates the ventralizing activity of BMP as an essential component of the signaling pathway. Therefore, we next tested whether Xmsx-1 is required in the ventralizing pathway triggered by BMP. To test this possibility, we analyzed marker gene expression in the dorsal marginal zone where BMP-4 was overexpressed alone or with VP-Xmsx-1. The results clearly showed that ventralization of mesoderm by BMP-4 is ef®ciently canceled by the coexpression of VP-Xmsx-1 (Fig. 7A) . Expression of the dorsal marker goosecoid, which was eliminated by BMP-4 overexpression, was completely restored by coexpressing VP-Xmsx-1. BMP-4-induced expression of the ventral markers Xvent-1 and Xwnt-8 was ef®ciently diminished by VP-Xmsx-1 overexpression. Given this fact, VP-Xmsx-1 should inhibit the ventralization of embryos induced by the BMP misexpression. We next evaluated the inhibiting activity of VP-Xmsx-1 against the ventralizing signal by the external appearance of tadpole stage embryos. UV treatment of fertilized embryos inhibits the cortical rotation to decide the dorsoventral axis and consequently leads to the misexpression of BMP-4 in the dorsalmost region of the gastrula (Fainsod et al., 1994) to ventralize the embryos. Thus, UVtreated embryos were injected with VP-Xmsx-1 mRNA. Ventralizing phenotypes by UV treatment (Av.DAI 1.63, n 35) (Fig. 7Ba) were partially rescued by the expression of VP-Xmsx-1 (Av.DAI 2.82, n 33) (Fig. 7Bb) . This result implies that VP-Xmsx-1 may inhibit BMP-4-induced ventralization. Given that the immediate early gene response of Xmsx-1 to the BMP signal occurs without protein synthesis, these results strongly support the idea that Xmsx-1 acts downstream of the BMP signal and is required for the ventralizing pathway triggered by BMP-4.
Discussion
Hierarchy of homeobox genes in the ventralizing pathway
Several homeobox genes, including Xmsx-1, Xvent-1, and Xvent-2, are known to be induced by BMP. In this study, we have shown by functional and induction analysis that there is an epistatic relationship between at least two ventralizing homeobox genes, Xmsx-1 and Xvent-1; that is, Xmsx-1 acts upstream of Xvent-1. Given that Xmsx-1 is a transcriptional repressor, it is reasonable to speculate the existence of at least one more factor between Xmsx-1 and Xvent-1 that is responsible for repressing Xvent-1 expression (`X' in Fig. 8). One of the candidates for the repressor X is goosecoid, since the homeobox gene is expressed speci®cally in Spemann's organizer of the gastrula (Cho et al., 1991) and was shown to act as a transcriptional repressor (Artinger et al., 1997) . In addition, the misexpression of goosecoid gene in the ventral marginal zone leads to the suppression of Xvent-1 expression (Gawantka et al., 1995) . A similar relationship has been reported between Xvent-2B and Xvent-1B which are members of the Xvent homeobox gene family, showing that Xvent-1B is not a direct target of BMP-signaling and is not activated by Xvent-2B in the expression level (Rastegar et al., 1999) . It was previously reported that Xmsx-1 and Xvent-2 were immediate early BMP-responding genes (Ladher et al., 1996; Suzuki et al., 1997b) . Furthermore, we have found that Xvent-2 expression is neither induced in the DMZ by wild-type Xmsx-1 nor suppressed by VP-Xmsx-1 (Fig. 6B) . These results suggest that Xmsx-1 and Xvent-2 may be acting in independent pathways, although both are triggered by BMP (Fig. 8) . The requirement for Xvent-2 in BMP-induced ventralization awaits further functional analyses.
Recently, xGATA-2, a member of the GATA family of zinc-®nger transcription factors, which is expressed in the ventral mesoderm during gastrulation and required for hematopoietic differentiation (Kelley et al., 1993; Walmsley et al., 1994) , has also been shown to induce Xvent-1 but not to affect Xvent-2 expression (Sykes et al., 1998) . Furthermore, ventral overexpression of a dominant interfering GATA factor resulted in the formation of an incomplete ectopic axis, inducing chordin and goosecoid and repressing Xwnt-8 (Sykes et al., 1998) , much like VP-Xmsx-1. Interestingly, xGATA-2 expression was upregulated by overexpression of Xmsx-1 in the DMZ (Fig. 4) and effectively downregulated by VP-Xmsx-1 in the VMZ (Fig. 3B) , suggesting that xGATA-2 acts downstream of Xmsx-1. However, unlike Xmsx-1, GATA factors neither affect ectodermal cell fate directly nor ventralize the mesoderm when expressed in their native form (Sykes et al., 1998) . Taken together, these results suggest that Xmsx-1 and GATA factors might share similar properties and function through a partially overlapping pathway to regulate mesoderm formation.
Does Xmsx-1 represent all BMP activities?
It is well understood that there are several homeobox genes that can mimic BMP activities, which include epidermal induction and neural inhibition. Therefore, we predict that there are redundant ventralizing pathways even within the BMP-regulated pathway. On the other hand, an attempt to rescue the dnBMPR-IA-induced dorsalized embryo by coexpressing wild-type Xmsx-1 demonstrated that Xmsx-1 is suf®cient to rescue the secondary body axis and restore the blocked BMP signal (data not shown). In the animal cap, Xmsx-1 also reversed the NCAM induction and epidermal keratin suppression caused by dnBMPR-IA (Suzuki et al., 1997b) . These results support our previous idea that Xmsx-1 can mediate all the ventralizing activities of BMP. In this study, we attempted to perform the reverse experiment by blocking BMP-induced ventralization with VP-Xmsx-1. In fact, VP-Xmsx-1 reversed the BMP-induced marker gene expression in the DMZ; the suppression of goosecoid and the increased levels of Xvent-1 and Xwnt-8 expression were returned to normal (Fig. 7A ). This result again supports the idea that Xmsx-1 mediates all testable activities of BMP. Moreover, we also showed that ventralizing phenotypes by UV treatment were partially rescued by dorsal expression of VP-Xmsx-1 (Fig. 7B ). This suggests that Xmsx-1 normally mediates endogenous ventralizing pathways, including BMP. However, when BMP-4 mRNA was injected dorsally alone or with VP-Xmsx-1 mRNA, the ventralization triggered by BMP-4 mRNA injection was not inhibited by coexpressing VP-Xmsx-1, evaluating the phenotypes of tadpole stage embryos (data not shown). In fact, the ventralized phenotype appeared to be even enhanced. There are possible explanations for this puzzling observation. One possibility is that the half-life of the VP-Xmsx-1 protein is limited and that its effect lasts only for a shorter period after translation than BMP-4. Another is that a redundant ventralizing pathway(s) is overactivated during the development of BMP-4-and VP-Xmsx-1-coinjected embryos, upon the inhibition of Xmsx-1 activity. Since marker gene expression was examined when sibling embryos reached stage 11, but the phenotype of the ventralized embryos was observed at stage 38, it is possible that such compensation occurred Fig. 8 . Model of the BMP-induced ventralizing signal in early development. Xmsx-1 induced by BMP signaling plays a major role in dorsoventral patterning in the early development of Xenopus laevis. Xmsx-1 acts as an inducer of Xvent-1, the next ventralizing factor, by suppressing the transcription of a yet-unidenti®ed transcriptional suppressor X for the Xvent-1 gene, and consequently, the Xmsx-1 expressing cells follow the ventral fate. The ventralizing signal from BMP and Xmsx-1, however, is also propagated to other redundant pathways including several other homeobox factors, Xvent-2 and Xmsx-2, and/or unknown factors (indicated by ?). Solid lines represent immediate early actions that occur without protein synthesis and broken lines represent the pathways that may be mediated by transcription of other factors. during that time. To test this possibility, we examined whether expression of other ventralizing genes was upregulated upon overexpression of VP-Xmsx-1. Although we examined the expression level of Xvent-2 and Smad-1 in the DMZ after the injection of VP-Xmsx-1, their expression levels were unchanged (data not shown), but the possibility remains that such a compensation mechanism exists for other ventralizing genes. The unrescued phenotype at the tadpole stage also suggests that dorsalization by VPXmsx-1 did not occur solely depending on the induction of chordin and noggin, though they are induced by VPXmsx-1, because if the dorsalization depends on them, BMP effects should be cancelled by VP-Xmsx-1 even at the late stage.
Xmsx-1 is a suppressor of organizer-speci®c genes
Recently, Laurent and Cho (1999) proposed a model whereby BMP activity ventralizes the area expressing BMP itself by interfering with the induction of organizerspeci®c genes such as goosecoid, which is stimulated by activin, Vg1, and nodal. goosecoid is induced by two homeobox genes, Xtwn and Xsia, regulated by the Wnt pathway. Laurent and Cho (1999) have shown that BMP signaling can antagonize the induction of goosecoid without affecting Wnt signaling at the level of Xtwn. These results suggest that the antagonistic activities of BMPs in organizer formation occur independently of twin regulation. Our present study has demonstrated that Xmsx-1 has a potent antagonistic activity in organizer formation, which includes suppression of the organizer-speci®c genes goosecoid and chordin. It is most likely that Xmsx-1 plays a major role in mediating the anti-organizer activity of BMP. In other words, BMP may antagonize organizer activity through Xmsx-1. Expression of goosecoid is regulated by the combination of two homeobox binding elements, distal element (DE) and proximal element (PE) (Watabe et al., 1995) . It is tempting to speculate that Xmsx-1 might mediate interference with the homeobox binding elements in the promoter region of goosecoid, directly or indirectly. This may lead to an interesting model regarding how the organizer is established, as organizer formation may require cancellation of the negative regulation of goosecoid expression by Xmsx-1. Speci®cally, there may be antagonism between Xmsx-1 and the goosecoid-activating homeobox proteins Xtwn and Xsia. All of these hypotheses need to be tested in the near future.
Experimental procedures
Constructs
Activating (VP-Xmsx-1) and repressing (eve-Xmsx-1) forms of Xmsx-1 were created by replacing the N-terminal 136 aa of Xmsx-1 with the 81 aa activation domain of VP16 protein (VP16 AD) to make VP-Xmsx-1 or the 269 aa repressor domain of the Drosophila even-skipped protein (eve RD) to make eve-Xmsx-1. The pCS2VP16 and pCS2eve plasmids, which contain the VP16 activation domain and the even-skipped repressor domain, respectively, were gifts from Ken W.Y. Cho. The negative control (DNXmsx-1) construct was created by fusing an initiation codon, ATG, to the sequence encoding the C-terminal half of the Xmsx-1 protein (amino acids 137±275). VP-Xvent-1 cDNA (a gift from Christof Niehrs) was subcloned into the pCS21 plasmid.
Manipulation of embryos
Unfertilized eggs were collected and fertilized in vitro as described previously (Suzuki et al., 1997a) . Embryos were dejellied using 3% cysteine and washed with water several times. Embryos were staged according to Nieuwkoop and Faber (1967) . The animal cap, ventral marginal zone (VMZ), and dorsal marginal zone (DMZ) were dissected at stage 8 for the animal cap and stage 10 for the marginal zones, and cultured in 0.1% BSA/1£ Steinberg's solution (Asashima et al., 1990) . UV irradiation of embryos was performed with a Stratalinker (Stratagene). Forty minutes after fertilization embryos were placed in water on quartz watch glass and irradiated.
Microinjection of synthetic mRNA
Each construct was linearized, and capped mRNAs were synthesized in vitro using the mMESSAGE mMACHINE sp6 kit (Ambion). Synthesized RNAs were injected into the animal pole or marginal zone of two-or four-cell stage embryos, respectively, in 3% Ficoll/0.1£ Steinberg's solution as described previously (Suzuki et al., 1997a) .
Reverse transcription-polymerase chain reaction (RT-PCR)
GAAGCCGTCCCT-3
